X2S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 8.85 EUR 1.14% Market Closed

Market Cap: €5.5B

	Sinopharm Group Co Ltd F:X2S1	CN
K	KDDI Corp DUS:DIP	JP
	Beijing Enterprises Water Group Ltd OTC:BJWTF	HK
C	Campbell Soup Co F:CSC	US
M	Mizuho Financial Group Inc XMUN:MZ8	JP
K	KDDI Corp OTC:KDDIY	JP
	Thomson Reuters Corp NASDAQ:TRI	CA
J	Jones Lang LaSalle Inc F:4J2	US
	Northam Platinum Holdings Ltd F:7JR	ZA
	Datadog Inc XETRA:3QD	US
	Standard Bank Group Ltd F:SKCS	ZA

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

9% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

3% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.